219 related articles for article (PubMed ID: 33104866)
1. Preventive therapeutic options for postoperative recurrence of ovarian endometrioma: gonadotropin-releasing hormone agonist with or without levonorgestrel intrauterine system insertion.
Zhu SY; Wu YS; Gu ZY; Zhang J; Jia SZ; Shi JH; Dai Y; Leng JH; Li XY
Arch Gynecol Obstet; 2021 Feb; 303(2):533-539. PubMed ID: 33104866
[TBL] [Abstract][Full Text] [Related]
2. Postoperative levonorgestrel-releasing intrauterine system versus oral contraceptives after gonadotropin-releasing hormone agonist treatment for preventing endometrioma recurrence.
Cho S; Jung JA; Lee Y; Kim HY; Seo SK; Choi YS; Lee JS; Lee BS
Acta Obstet Gynecol Scand; 2014 Jan; 93(1):38-44. PubMed ID: 24605384
[TBL] [Abstract][Full Text] [Related]
3. Postoperative Levonorgestrel-Releasing Intrauterine System Insertion After Gonadotropin-Releasing Hormone Agonist Treatment for Preventing Endometriotic Cyst Recurrence: A Prospective Observational Study.
Kim MK; Chon SJ; Lee JH; Yun BH; Cho S; Choi YS; Lee BS; Seo SK
Reprod Sci; 2018 Jan; 25(1):39-43. PubMed ID: 28683602
[TBL] [Abstract][Full Text] [Related]
4. Postoperative maintenance levonorgestrel-releasing intrauterine system and endometrioma recurrence: a randomized controlled study.
Chen YJ; Hsu TF; Huang BS; Tsai HW; Chang YH; Wang PH
Am J Obstet Gynecol; 2017 Jun; 216(6):582.e1-582.e9. PubMed ID: 28209488
[TBL] [Abstract][Full Text] [Related]
5. Levonorgestrel-releasing intrauterine device (LNG-IUD) for symptomatic endometriosis following surgery.
Abou-Setta AM; Al-Inany HG; Farquhar CM
Cochrane Database Syst Rev; 2006 Oct; (4):CD005072. PubMed ID: 17054236
[TBL] [Abstract][Full Text] [Related]
6. Postoperative hormonal treatment for prevention of endometrioma recurrence after ovarian cystectomy: a systematic review and network meta-analysis.
Wattanayingcharoenchai R; Rattanasiri S; Charakorn C; Attia J; Thakkinstian A
BJOG; 2021 Jan; 128(1):25-35. PubMed ID: 32558987
[TBL] [Abstract][Full Text] [Related]
7. The role of levonorgestrel-releasing intrauterine system for recurrence prevention after conservative surgery among patients with coexistent ovarian endometrioma and diffuse adenomyosis: A retrospective case control study with long-term follow up.
Shi JH; Zhu SY; Li XY; Dai Y; Leng JH
J Gynecol Obstet Hum Reprod; 2023 May; 52(5):102572. PubMed ID: 36914113
[TBL] [Abstract][Full Text] [Related]
8. The efficacy of long-term maintenance therapy with a levonorgestrel-releasing intrauterine system for prevention of ovarian endometrioma recurrence.
Kim ML; Cho YJ; Kim MK; Jung YW; Yun BS; Seong SJ
Int J Gynaecol Obstet; 2016 Sep; 134(3):256-9. PubMed ID: 27346551
[TBL] [Abstract][Full Text] [Related]
9. Levonorgestrel-releasing intrauterine device (LNG-IUD) for symptomatic endometriosis following surgery.
Abou-Setta AM; Houston B; Al-Inany HG; Farquhar C
Cochrane Database Syst Rev; 2013 Jan; (1):CD005072. PubMed ID: 23440798
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the efficacy of diegnogest and levonorgestrel-releasing intrauterine system after laparoscopic surgery for endometriosis.
Lee KH; Jung YW; Song SY; Kang BH; Yang JB; Ko YB; Lee M; Han HY; Yoo HJ
J Obstet Gynaecol Res; 2018 Sep; 44(9):1779-1786. PubMed ID: 29974633
[TBL] [Abstract][Full Text] [Related]
11. [Effects of levonorgestrel-releasing intrauterine system on pain and recurrence associated with endometriosis and adenomyosis].
Deng S; Lang JH; Leng JH; Liu ZF; Sun DW; Zhu L
Zhonghua Fu Chan Ke Za Zhi; 2006 Oct; 41(10):664-8. PubMed ID: 17199919
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the hemostatic effects of a levonorgestrel-releasing intrauterine system and leuprolide acetate in women with endometriosis: a randomized clinical trial.
Yamaguti EM; Brito MB; Ferriani RA; Garcia AA; Rosa-e-Silva JC; Vieira CS
Thromb Res; 2014 Dec; 134(6):1193-7. PubMed ID: 25283586
[TBL] [Abstract][Full Text] [Related]
13. Uterine ultrasonographic changes during endometriosis treatment: a comparison between levonorgestrel-releasing intrauterine devices and a gonadotropin-releasing hormone agonist.
Manetta LA; de Paula Martins W; Rosa e Silva JC; de Sá Rosa e Silva AC; Nogueira AA; Ferriani RA
Ultrasound Med Biol; 2008 Dec; 34(12):1914-8. PubMed ID: 18597921
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of levonorgestrel releasing intrauterine system as a postoperative maintenance therapy of endometriosis: A meta-analysis.
Song SY; Park M; Lee GW; Lee KH; Chang HK; Kwak SM; Yoo HJ
Eur J Obstet Gynecol Reprod Biol; 2018 Dec; 231():85-92. PubMed ID: 30336309
[TBL] [Abstract][Full Text] [Related]
15. Effects of the levonorgestrel-releasing intrauterine system on cardiovascular risk markers in patients with endometriosis: a comparative study with the GnRH analogue.
Ferreira RA; Vieira CS; Rosa-E-Silva JC; Rosa-e-Silva AC; Nogueira AA; Ferriani RA
Contraception; 2010 Feb; 81(2):117-22. PubMed ID: 20103448
[TBL] [Abstract][Full Text] [Related]
16. Levonorgestrel intrauterine system for endometrial protection in women with breast cancer on adjuvant tamoxifen.
Dominick S; Hickey M; Chin J; Su HI
Cochrane Database Syst Rev; 2015 Dec; 2015(12):CD007245. PubMed ID: 26649916
[TBL] [Abstract][Full Text] [Related]
17. [Levonorgestrel-releasing intrauterine system and combined oral contraceptives as conservative treatments for recurrent ovarian endometriosis: a comparative clinical study].
Xu XW; Wang LD; Zhu XQ; Yan LZ; Guan YT; Zhu SC; Hu Y
Zhonghua Yi Xue Za Zhi; 2011 Apr; 91(15):1047-50. PubMed ID: 21609640
[TBL] [Abstract][Full Text] [Related]
18. Gonadotropin releasing hormone agonist and levonorgestrel-intrauterine device followed by in vitro fertilization program as management strategy for an infertile endometrial cancer patient: a case report.
Nucera G; Mandato VD; Gelli MC; Palomba S; La Sala GB
Gynecol Endocrinol; 2013 Mar; 29(3):219-21. PubMed ID: 23153053
[TBL] [Abstract][Full Text] [Related]
19. Postoperative administration of dienogest plus estradiol valerate versus levonorgestrel-releasing intrauterine device for prevention of pain relapse and disease recurrence in endometriosis patients.
Morelli M; Sacchinelli A; Venturella R; Mocciaro R; Zullo F
J Obstet Gynaecol Res; 2013 May; 39(5):985-90. PubMed ID: 23551827
[TBL] [Abstract][Full Text] [Related]
20. Postoperative maintenance levonorgestrel-releasing intrauterine system for symptomatic uterine adenomyoma.
Lin CJ; Hsu TF; Chang YH; Huang BS; Jiang LY; Wang PH; Chen YJ
Taiwan J Obstet Gynecol; 2018 Feb; 57(1):47-51. PubMed ID: 29458902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
